Skip to main content
SpringerLink
Log in

Nmr contrast enhancement of brain tumours: comparison of the blood brain barrier tracer GdDTPA and the tumour-selective contrast agent MnTPPS

  • Papers
  • Published:
Magma Aims and scope Submit manuscript

Abstract

Contrast enhancement of two different NMR contrast agents, GdDTPA and MnTPPS, was compared. Sequential recording ofT 1-weighted images at 50s intervals allowed the observation of the temporal and spatial evolution of the contrast effect in rats with glioma implanted into the right brain hemisphere. The maximum signal intensity ratio of tumour over contralateral striatum was 1.80±0.10 for GdDTPA and 1.61±0.15 for MnTPPS. The enhancement was maximal 3min after application of GdDTPA and fell rapidly to reach half maximum after 24 min. MnTPPS led to maximum tumour enhancement within 11 min and did not return to control level within the observation period (150 min). In the peritumoural edema, an enhancement effect was absent for MnTPPS, but GdDTPA spread out from the tumour resulting in a delayed but strong enhancement outside the tumour. Thus, GdDTPA, as a blood-brain-barrier tracer, led only to a transient contrast enhancement between tumour and surrounding tissue and no unambiguous demarcation of the tumour against peritumoural edema. Application of MnTPPS resulted in a long-lasting strong tumour enhancement and reliable delineation from peritumoural edema.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Schörner W, Laniado M, Kornmesser W and Felix R (1989)Neuroradiology 31 140–147.

    PubMed  Google Scholar 

  2. Schubeus P, Schörner W and Haustein J (1991)Magn Reson Med 22 249–254.

    PubMed  Google Scholar 

  3. Healy ME, Hesselink JR, Press GA and Middleton MS (1987)Radiology 165 619–624.

    PubMed  Google Scholar 

  4. Policard A (1924)CR Soc Biol (Paris)91 1423–1424.

    Google Scholar 

  5. Tsutsui M, Carrano CJ and Tsutsui EA (1975)Ann NY Acad Sci 244 674–684.

    PubMed  Google Scholar 

  6. Winkelman J (1962)Cancer Res 22 589–596.

    PubMed  Google Scholar 

  7. Nelson JA, Schmiedl U and Shankland EG (1990)Invest Radiol 25 71–73.

    Google Scholar 

  8. Chen CW, Cohen JS, Myers CE and Sohn M (1984)FEBS Lett 168 70–74.

    PubMed  Google Scholar 

  9. Bockhorst K, Hoehn-Berlage M, Kocher M and Hossmann K-A (1990)Magn Reson Imag 8 499–504.

    Google Scholar 

  10. Wilmes LJ, Hoehn-Berlage M, Els T, Bockhorst K, Eis M, Bonnekoh P and Hossmann K-A (1993)J Magn Reson Imag 3 5–12.

    Google Scholar 

  11. Hoehn-Berlage M, Norris D, Bockhorst K, Ernestus R-I, Kloiber O, Bonnekoh P, Leibfritz D and Hossmann K-A (1992)Magn Reson Med 27 201–213.

    PubMed  Google Scholar 

  12. Tofts PS and Kermode AG (1991)Magn Reson Med 17 357–367.

    PubMed  Google Scholar 

  13. Kenney J, Schmiedl U, Maravilla K, Starr F, Graham M, Spence A and Nelson J (1992)Magn Reson Med 27 68–75.

    PubMed  Google Scholar 

  14. Brant-Zawadzki M, Berry I, Osaki L and Brasch R (1986)Contrast agents in magnetic resonance imaging (Runge VM, Claussen C, Felix R and James AE Eds) pp. 118–120. Excerpta medica Amsterdam.

  15. Hossmann K-A, Hürter T and Oschlies U (1983)Ada Neuropathol (Berlin)60 223–231.

    Google Scholar 

  16. Bockhorst K, Hoehn-Berlage M, Ernestus R-I, Tolxdorff T and Hossmann K-A (1993)Magn Reson Imag 11(5): 655–663.

    Google Scholar 

  17. Lyon RC, Faustino PJ, Cohen JS, Katz A, Mornex F, Colcher D, Baglin C, Koenig SH and Hambright P (1987)Magn Reson Med 4 24–33.

    PubMed  Google Scholar 

  18. Ernestus R-I, Wilmes LJ and Hoehn-Berlage M (1992)Clinical & Experimental Metastasis 10 345–350.

    Google Scholar 

  19. Eis M, Hoehn-Berlage M, Bockhorst K and Hossmann K-A (1991) InBook of abstracts: Tenth Annual Meeting of the Society of Magnetic Resonance in Medicine. Berkeley, CA: p. 701.

  20. Weinmann HJ (1986) Chelated contrast agents. In:Contrast agents in magnetic resonance imaging (Runge VM, Claussen C, Felix R, James AE Eds) pp. 111–113. Excerpta medica Amsterdam.

  21. Schörner W, Felix R, Laniado M, Lange M, Weinmann HJ, Claussen C, Fiegler W, Speck U and Kazner E (1984)Fortschr Röntgenstr 140 493–500.

    Google Scholar 

  22. Brasch RC (1983)Radiology 147 781–788.

    PubMed  Google Scholar 

  23. Weinmann HJ, Brasch RC, Press WE and Wesbey GE (1984)Amer J Roentgenol 142 619–624.

    Google Scholar 

  24. Carr DH, Brown J, Bydder GM, Weinmann HJ, Speck U, Thomas DJ and Young IR (1984)Lancet 1 484–486.

    PubMed  Google Scholar 

  25. Felix R, Schörner W, Laniado M, Niendorf HP, Claussen C, Fiegler W and Speck U (1985)Radiology 156 681–688.

    PubMed  Google Scholar 

  26. Verma A, Nye JS and Snyder SH (1987)Proc Natl Acad Sci USA 84 2256–2260.

    PubMed  Google Scholar 

  27. Snyder SH, Verma A and Trifiletti RR (1987)FASEB J 1 282–288.

    PubMed  Google Scholar 

  28. Ikezaki K, Nomura T, Takahashi M, Fritz-Zieroth B and Fukui M (1993)Acta Neurochirur. in press.

  29. Gal D, MacDonald PC, Porter JC and Simpson ER (1981)Int J Cancer 28 315–319.

    PubMed  Google Scholar 

  30. Maziere JC, Santus R, Morliere P, Reyftmann JP, Candide C, Mora L, Salmon S, Maziere C, Gatt S and Dubertret L (1990)J Photochem Photobiol B 6 61–68.

    PubMed  Google Scholar 

  31. Morliere P, Momenteau M, Candide C, Simonin V, Santus R, Maziere JC, Dubertret L, Goldstein S and Hüppe G (1990)J Photochem Photobiol B 5 49–67.

    PubMed  Google Scholar 

  32. Maziere JC, Morliere P and Santus RJ (1991)J Photochem Photobiol B 8 351–360.

    PubMed  Google Scholar 

  33. Ogan MD, Revel D and Brasch RC (1987)Invest Radiol 22 822–828.

    PubMed  Google Scholar 

  34. Hambright P (1977)J Inorg Chem 39 1102.

    Google Scholar 

  35. Ito U, Reulen H-J and Huber P (1986)Ada Neurochir. 81 53–60.

    Google Scholar 

  36. Reulen H-J, Graber S, Huber P and Ito U (1988)Ada Neurochir. (Wien) 95 19–24.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Max-Planck-Institute for Neurological Research, Cologne, Germany

    Thomas Els, Kurt Bockhorst & Mathias Hoehn-berlage

Authors
  1. Thomas Els
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kurt Bockhorst
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mathias Hoehn-berlage
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Els, T., Bockhorst, K. & Hoehn-berlage, M. Nmr contrast enhancement of brain tumours: comparison of the blood brain barrier tracer GdDTPA and the tumour-selective contrast agent MnTPPS. MAGMA 1, 126–133 (1993). https://doi.org/10.1007/BF01769414

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01769414

Keywords

Search

Navigation